Inner Cosmos

Inner Cosmos is a neurotechnology company developing the Digital Pill, a minimally invasive brain-computer interface (BCI) implanted under the scalp to treat treatment-resistant depression. The penny-sized device delivers imperceptible micro-stimulations to rebalance brain networks, combining an extracranial implant with an external magnetic power pod for at-home use. Inner Cosmos completed the first FDA-approved Early Feasibility Study for depression in nearly 20 years, achieving full remission in multiple patients. The company's approach sits between non-invasive wearables and invasive deep brain stimulation, offering a one-hour outpatient implant procedure with results comparable to or exceeding TMS therapy.